| | 
Part, Chapter, Paragraph
1 -, 1 | the European Commission D. G. Health and Consumers (http://
2 I, 2. 11 | Nanotechnology. htt ch~Oberdörster G. et al., (2005): Nanotoxicology:
3 I, 3. 4 | 3.4. References~ ~Beets G, Dourleijn E, Liefbroer
4 I, 3. 4 | 591-611.~ ~Esveldt, I., G. Beets, K. Henkens, A. Liefbroer &
5 II, 5. 2. 4 | moderate alcohol intake (20-30 g/day in men and 10-20 g/day
6 II, 5. 2. 4 | 30 g/day in men and 10-20 g/day in women) is associated
7 II, 5. 2. 6 | intake to less than 1,5 g (3,8 g) per day, an increased
8 II, 5. 2. 6 | to less than 1,5 g (3,8 g) per day, an increased intake
9 II, 5. 2. 6 | Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina
10 II, 5. 2. 6 | 1166.~Lewington S, Whitlock G, Clarke R, Sherliker P,
11 II, 5. 2. 7 | Vanuzzo D, Pilotto L, Cesana G, Ferrario M, Chiodini P,
12 II, 5. 2. 7 | Vanuzzo D, Chiodini P, Cesana G, Ferrario M, Mattiello A,
13 II, 5. 3. 9 | 1005.~ ~Coleman MP, Gatta G, Verdecchia A, Estève J,
14 II, 5. 3. 9 | Oncol 18(3):581-592.~ ~Gatta G, Capocaccia R, Stiller C,
15 II, 5. 3. 9 | Appleby P, Barnes I, Reeves G, Endogenous Hormones and
16 II, 5. 3. 9 | J, Grosclaude P, Hédelin G, Matsuda T, Moller H, Moller
17 II, 5. 3. 9 | Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani
18 II, 5. 3. 9 | Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler
19 II, 5. 5.Int(11)| and Depression. In: Sen. G., A. George, and P. Östlin (
20 II, 5. 5.Int(12)| Diderichsen, A. Härenstam and G. Lindberg (eds) Gender Inequalities
21 II, 5. 5. 1 | Lépine JP, de Girolamo G, Vilagut G, Gasquet I, Torres
22 II, 5. 5. 1 | de Girolamo G, Vilagut G, Gasquet I, Torres JV, Kovess
23 II, 5. 5. 2 | Townsend J, Surr C, Boyle G and Brooker D (2005): Summary
24 II, 5. 5. 3 | Sjöström M, Hillger C, Neumann G, Kirch W (in press, due
25 II, 5. 5. 3 | 12 Suppl 1:74-77.~Andrews G, Sandersson K, Corry J,
26 II, 5. 5. 3 | Schulze B, Bertocchi E, Rossi G, Ghilardi A, Pioli R (2007):
27 II, 5. 5. 3 | Bernert S, de Girolamo G, Morosini P, Polidori G,
28 II, 5. 5. 3 | G, Morosini P, Polidori G, Kikkawa T, Kawakami N,
29 II, 5. 5. 3 | Medina-Mora ME, Borges G, Lara C, de Graaf R, Ormel
30 II, 5. 5. 3 | Alonsro J, Haro JM, Vilagut G, Bromet EJ, Gluzman S, Webb
31 II, 5. 5. 3 | Austin R, Jones-Edwards G, Roberts AP (2006): Lifetime
32 II, 5. 5. 3 | Linszen D, Birchwood M, Juckel G, Morrirson A, Vázquèz-Barquero
33 II, 5. 5. 3 | Mossialos E, Thornicroft G (2007): Mental Health Policy
34 II, 5. 5. 3 | Mackeprang T, Hansson L, Werdelin G, Karlsson H, Bjarnason O,
35 II, 5. 5. 3 | Garety P, Geddes J, Orbach G, Morgan C (2002): Psychological
36 II, 5. 5. 3 | 5):763-82.~Pitschel-Walz G, Bäuml J (2007): Psychotherapie
37 II, 5. 5. 3 | 55.~Silverstone T, Smith G, Goodall E (1988): Prevalence
38 II, 5. 5. 3 | 330.~Wölwer W, Buchkremer G, Häfner H, Klosterkötter
39 II, 5. 5. 3 | S9-S14.~Forsgren L, Bucht G, Erksson S, Bergmark L (
40 II, 5. 5. 3 | Epilepsia 45:1613-1622.~Gallitto G, Serra S, La Spina P, et
41 II, 5. 5. 3 | Hauser WA, Gudmundsson G (1998): Long-term survival
42 II, 5. 5. 3 | Ludvigsson P, Gudmundsson G, et al (2005): Incidence
43 II, 5. 5. 3 | 445-450.~Sheth SG, Krauss G, Krumholz A. Li G (2004):
44 II, 5. 5. 3 | Krauss G, Krumholz A. Li G (2004): Mortality in epilepsy:
45 II, 5. 5. 3 | Europe~Baumhackl U, Eibl G, Ganzinger U, et al (2002):
46 II, 5. 5. 3 | Neurol 253:914-918.~Dean G, Elian M, Galea de Bono
47 II, 5. 5. 3 | 277.~Ekestern E, Lebhart G (2004). Mortality from multiple
48 II, 5. 5. 3 | Grønlie SA, Myrvoll E, Hansen G, et al (2000): Multiple
49 II, 5. 5. 3 | In: Battaglia MA, Crimi G (eds): An Update on Multiple
50 II, 5. 5. 3 | Donald WI, Compston A, Edan G, et al (2001): Recommended
51 II, 5. 5. 3 | 576.~Middleton LT, Dean G (1991): Multiple sclerosis
52 II, 5. 5. 3 | Pugliatti M, Sotgiu S, Solinas G et al (2001): Multiple sclerosis
53 II, 5. 5. 3 | Pugliatti M, Sotgiu S, Rosati G (2002): The worldwide prevalence
54 II, 5. 5. 3 | 134.~Pugliatti M, Rosati G, Carton H, et al (2006):
55 II, 5. 5. 3 | 722.~Pugliatti M, Rosati G (in press): Epidemiology
56 II, 5. 5. 3 | Psychiatry 59:71–76.~Rosati G (2001). The prevalence of
57 II, 5. 5. 3 | Pugliatti M, Lauer L, Kobelt G (2007): Estimation of the
58 II, 5. 5. 3 | Alessandro R, Gamberini G, Granieri E, Benassi G,
59 II, 5. 5. 3 | Gamberini G, Granieri E, Benassi G, Naccarato S, Manzaroli
60 II, 5. 5. 3 | FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (
61 II, 5. 5. 3 | E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P,
62 II, 5. 5. 3 | Suppl 1:68-73.~Logroscino G (2005): The role of early
63 II, 5. 5. 3 | Klotsche J, Spottke A, Deuschl G, Forstl H, Henn F, Heuser
64 II, 5. 5. 3 | neurology 255(2):255-264.~Rosati G, Granieri E, Pinna L, Devoto
65 II, 5. 5. 3 | neurologica 1(4):303-308.~Rosati G, Granieri E, Pinna L, Aiello
66 II, 5. 5. 3 | 243-254.~Späte HF, Gemende G, Gemende I (1988): Psychosocial
67 II, 5. 5. 3 | Siebert U, Oertel WH, Ulm G, Dodel R (2005): Cost of
68 II, 5. 6. 6 | R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K,
69 II, 5. 6. 6 | Andersson HI, Ejlertsson G, Leden I, Rosenberg C (1993):
70 II, 5. 6. 6 | Brage S, Nygard JF, Tellnes G (1998): The gender gap in
71 II, 5. 6. 6 | M, Emery P, Ferraccioli G, Hazes JM, Klareskog L,
72 II, 5. 6. 6 | 63S-7S~Lin CT, Albertson G, Price D, Swaney R, Anderson
73 II, 5. 6. 6 | Allgar V, Jones K, Marples G, Chandler C, Dawson P (1999):
74 II, 5. 6. 6 | Geneva~ ~Symmons D, Turner G, Webb R, Asten P, Barrett
75 II, 5. 6. 6 | Roxby M, Simmons A, Williams G (1998): Estimating the burden
76 II, 5. 7. 7 | Diseases; 2005.~Ardissino G, Dacco V, Testa S, Bonaudo
77 II, 5. 7. 7 | 99):S16-S19.~Pontoriero G, Pozzoni P, Vecchio LD,
78 II, 5. 7. 7 | DH, Gullion CM, Nichols G, Keith DS, Brown JB (2004):
79 II, 5. 8. 7 | Schwartz D, Toren K, Viegi G (2003): American Thoracic
80 II, 5. 8. 7 | Bonnefoy X, Carrozzi L, Viegi G, Charpin D, Annesi-Maesano
81 II, 5. 8. 7 | Beccaria M, Marinoni A, Viegi G, de Marco R (2003): Chronic
82 II, 5. 8. 7 | Fournier M, Housset B, Huchon G, Huas D, Godard P, Voinet
83 II, 5. 8. 7 | Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G,
84 II, 5. 8. 7 | Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta
85 II, 5. 8. 7 | Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi
86 II, 5. 8. 7 | 1916-1923.~ ~Gudmundsson G, Gislason T, Lindberg E,
87 II, 5. 8. 7 | 115–122.~ ~MacNee W, Viegi G, Kamel N (2007): New opportunities
88 II, 5. 8. 7 | Maier WC, Egger P, Visick G, Thakrar B, Sykes J, Pride
89 II, 5. 8. 7 | 126: 81-89.~ ~Stratelis G, Jakobsson P, Molstad S,
90 II, 5. 8. 7 | 100: 1349-1355.~ ~Viegi G, Pedreschi M, Pistelli F,
91 II, 5. 8. 7 | 117: 339S-345S.~ ~Viegi G, Mattelli G, Angino A, Scognamiglio
92 II, 5. 8. 7 | 339S-345S.~ ~Viegi G, Mattelli G, Angino A, Scognamiglio
93 II, 5. 8. 7 | Bednarek M, Gorecka D, Viegi G, Hurd SS, Fukuchi Y, Lai
94 II, 5. 9. 7 | Fahlbusch B, Schlenvoigt G, Bischof W, Wichmann HE (
95 II, 5. 9. 7 | Figures, ERJ~ ~Mantovani L G, Bettoncelli G, Cricelli
96 II, 5. 9. 7 | Mantovani L G, Bettoncelli G, Cricelli C, Sessa E, Mazzaglia
97 II, 5. 9. 7 | Cricelli C, Sessa E, Mazzaglia G, Canonica GW, Passalacqua
98 II, 5. 9. 7 | Canonica GW, Passalacqua G (2007): Allergic rhinitis
99 II, 5. 9. 7 | 2004; 59:632-636~ ~Verlato G, de Marco R (2003): Is the
100 II, 5. 10. 7 | Herouet-Guicheney C, Ladics G, Bannon G, Cockburn A, Crevel
101 II, 5. 10. 7 | Herouet-Guicheney C, Ladics G, Bannon G, Cockburn A, Crevel R, Fitzpatrick
102 II, 5. 11. 3 | prevalence=5.8%~Girolomoni G, et al~ ~Danish school children (
103 II, 5. 11. 3 | M Gonç , T Corr a, G Pessoa, A Bapt a, M Pece o,
104 II, 5. 11. 7 | 2003.~ ~Ceylan C, Ozturk G, Alper S (2003): Non-melanomatous
105 II, 5. 11. 7 | 456-60.~ ~Plesko I, Severi G, Obsitnikova A, Boyle P.
106 II, 5. 12. 7 | Cancer 86:157-169.~ ~Corrao G, Ferrari P, Zambon A, Torchio
107 II, 5. 12. 7 | Epidemiol 26:100-109.~ ~Corrao G, Aricò S (1998): Independent
108 II, 5. 12. 7 | Esposito D, Mele A, Ortolani G, Adamo B, Rapicetta M, Forte
109 II, 5. 12. 7 | Vergara M, Martin -~ ~Ioannou G, Doust J, Rockey DC (2003):
110 II, 5. 12. 7 | K, Vanlemmens C, Mantion G, Messner M, Launois B, Samuel
111 II, 6. 4. 5 | purposes in feed and food; g) give particular attention
112 II, 7. 7 | 2008].~ ~Bauer R, Nossek G, Steiner M (2007): Freizeitunfallstatistik
113 II, 7. 7 | Peden M, McGee K, Sharma G.~ ~Racioppi F, Eriksson
114 II, 8. 2. 1 | J., Allan, L., Martin, G. and Robinson, N. (2006).
115 II, 8. 2. 1 | Quarter 2004, 48-53~Fujiura, G.T., Park, H. J. and Rutkowski-Kmitta,
116 II, 8. 2. 1 | Cooper S-A, Davis R, Fujiura G, Heller T, Holland A, Krahn
117 II, 8. 2. 1 | Heller T, Holland A, Krahn G, Lennox N, Meaney J & Wehmeyer
118 II, 8. 2. 1 | Lantman-de Valk, F.G. Schellevis, G.J. Dinant (2007). Health
119 II, 8. 2. 1 | Garrido-Cumbrera, M., van Hove, G., Björkman, M., Ceccotto,
120 II, 8. 2. 1 | R., Kamper, M., Weber, G., Heiss, C., Haveman, M.,
121 II, 8. 2. 3 | Quaranta A, Assennato G, Sallustio V (1996): Epidemiology
122 II, 9. 1. 1 | begin at 22 weeks or 500 g, but that fetal mortality
123 II, 9. 1. 1 | birth weight less than 2500 g, most recent data available~ ~
124 II, 9. 1. 1 | Langer M, Vutuc C, Lindmark G (2003): Maternal health
125 II, 9. 1. 1 | Macfarlane A, Gissler M, Breart G, Zeitlin J (2006): Preterm
126 II, 9. 1. 1 | Bouvier-Colle MH, Varnoux N, Breart G (1995): Maternal deaths
127 II, 9. 1. 1 | 1995;58(1):3-7.~ ~Breart G, Barros H, Wagener Y, Prati
128 II, 9. 1. 1 | B, Caneva MP, Schlaeder G (1997) : La surveillance
129 II, 9. 1. 1 | Cans C, Johnson A, Surman G, Topp M, Torrioli MG, et
130 II, 9. 1. 1 | very low birthweight (<1500 g) or born prematurely (<32
131 II, 9. 1. 1 | Blondel B, Alexander S, Breart G (2007): Variation in rates
132 II, 9. 1. 1 | Zeitlin J, Wildman K, Breart G, Alexander S, Barros H,
133 II, 9. 1. 2 | appropriate policy response.~ ~g) Much greater investment
134 II, 9. 1. 2 | Vol 76, pp 693-705.~Bréart G, Barros H, Wagener Y, Prati
135 II, 9. 1. 2 | C, McDonnell R, Scarano G, Calzolari E, Neville A,
136 II, 9. 1. 2 | Calzolari E, Neville A, Cocchi G, Bianca S, Gatt M, de Walle
137 II, 9. 1. 2 | Robert-Gnansia E, Daltveit, A, Aneren G, Ollars B, Edwards G (2005a): "
138 II, 9. 1. 2 | Aneren G, Ollars B, Edwards G (2005a): "Preventing Neural
139 II, 9. 1. 2 | Vigan C, Fevotte J, Kiel G, Mandereau L, for the Occupational
140 II, 9. 1. 2 | Dolk H, de Vigan C, Scarano G, Tucker D, Stoll C et al (
141 II, 9. 2. 7 | Rigby M, Hillger C, Neumann G, Kirch W (2008): Challenges
142 II, 9. 3. 1 | accessed 11.07.07~ ~Aus G, Bergdahl S, Lodding P,
143 II, 9. 3. 1 | 262~ ~Braun, M., Wassner, G Klotz, T Reifenrath, B Mathers,
144 II, 9. 3. 1 | Glei DA, Bruzzone S Caselli G (2005): Effects of war losses
145 II, 9. 3. 1 | Obesity, London.~ ~Jackson, G; Padley, S (2008) Erectile
146 II, 9. 3. 1 | 8(9): 784-796.~ ~Verlato G, Calabrese R, De Marco R (
147 II, 9. 3. 2 | Langer M, Vutuc C, Lindmark G (2003): Maternal health
148 II, 9. 3. 2 | Macfarlane A, Gissler M, Breart G, Zeitlin J (2006): Preterm
149 II, 9. 3. 2 | Bouvier-Colle MH, Varnoux N, Breart G (1995): Maternal deaths
150 II, 9. 3. 2 | 1995;58(1):3-7.~ ~Breart G, Barros H, Wagener Y, Prati
151 II, 9. 3. 2 | B, Caneva MP, Schlaeder G (1997) : La surveillance
152 II, 9. 3. 2 | Cans C, Johnson A, Surman G, Topp M, Torrioli MG, et
153 II, 9. 3. 2 | very low birthweight (<1500 g) or born prematurely (<32
154 II, 9. 3. 2 | van Roosmalen J, Dekker G, van Dongen P, van Geijn
155 II, 9. 3. 2 | Blondel B, Alexander S, Breart G (2007): Variation in rates
156 II, 9. 3. 2 | Zeitlin J, Wildman K, Breart G, Alexander S, Barros H,
157 II, 9. 3. 3 | gender-related issues” (e.g.violence).~ ~On 3 July 2002,
158 II, 9. 3. 3 | Del Amo J, Broring G, Hamers FF, Infuso A, Fenton
159 II, 9. 3. 3 | Qual A, Rundle K, Cousins G, Donnelly C, Mulcahy F,
160 II, 9. 3. 3 | Shepherd J, Weston R, Peersman G, Napuli IZ, Interventions
161 II, 9. 4. 7 | 10.07.07~ ~Cattaneo, A. G. (2007): Tuberculosis surveillance
162 II, 9. 5. 6 | F, Härenstam A, Lindberg G). Harvard Center for Development
163 II, 9. 5. 6 | 10) 2221-2232~Heinrich G A (2000): Affluence And
164 II, 9. 5. 6 | Publications~ ~Lindholm G (1995): ÎSkolgrden, -vuxnas
165 II, 9. 5. 6 | 1), pp. 13-28.~ ~Risberg G, Hamber K, Johansson E (
166 III, 10. 1. 3 | Brasel JA, Lee W-NP, Burke G, Cooper DM (1998): Fitness
167 III, 10. 1. 3 | Alcohol 13:387-405.~Dahlgren, G. & Whitehead, M. (1991):
168 III, 10. 1. 3 | Circulation 90:2581-2590.~Gmel G, Rehm J (2003): Harmful
169 III, 10. 2. 1 | between 0.8g/l and 0.99 g/L.~There is a relationship
170 III, 10. 2. 1 | a consumption of 15-30 g ethanol /day throughout
171 III, 10. 2. 1 | Caetano R, Casswell S, Edwards G, Giesbrecht N, Graham K,
172 III, 10. 2. 1 | Gherunpong S, Tsakos G, Sheiham A. A s s. Int J
173 III, 10. 2. 1 | Lingstrom P, Mejare I, Norderam G, Norlund A, Petersson LG,
174 III, 10. 2. 1 | pdf].~ ~Evans J, Roberts G (1987): Physical competence
175 III, 10. 2. 1 | Dietary-history~28~Mensink G B M et.al. (2004) Food and
176 III, 10. 2. 1 | birth weight (over 4500 g or above the 95th percentile
177 III, 10. 2. 1 | survey: summary statistics. G’Mangia, Department of Health
178 III, 10. 2. 1 | in Hungarian).~ ~Boström G (2007): Resultat från nationella
179 III, 10. 2. 1 | October 2007).~ ~Bostrom G, Diderichsen F (1997): Socioeconomic
180 III, 10. 2. 1 | Zuccaro P, Negri E, Apolone G, La Vecchia C (2006): Overweight
181 III, 10. 2. 1 | Friel S, Corrigan H, Nolan G, Sixsmith J, Walsh O, Cooke
182 III, 10. 2. 1 | Bíró L, Greiner F, Zajkás G, Szórád I, Varga A, Domonkos
183 III, 10. 2. 1 | Peeters PH, Engeset D, Skeie G, Aller A, Amiano P, Berglund
184 III, 10. 2. 1 | Aller A, Amiano P, Berglund G, Nilsson S, McTaggart A,
185 III, 10. 2. 1 | V, Evangelista A, Frasca G, Bueno-de-Mesquita HB, van
186 III, 10. 2. 1 | Schouw YT, Engeset D, Skeie G, Tormo MJ, Ardanaz E, Charrondiere
187 III, 10. 2. 1 | Ocke MC, Peeters PH, Skeie G, Engeset D, Charrondiere
188 III, 10. 2. 1 | Bueno-De-Mesquita HB, Ocke MC, Skeie G, Kumle M, Dorronsoro Iraeta
189 III, 10. 2. 1 | P, Kalapothaki V, Masala G, Giurdanella MC, Norat T,
190 III, 10. 2. 1 | Vasilopoulou E, Bellos G, Pala V, Masala G, Tumino
191 III, 10. 2. 1 | Bellos G, Pala V, Masala G, Tumino R, Sacerdote C,
192 III, 10. 2. 1 | Peeters PH, Engeset D, Skeie G, Slimani N, Riboli E (2006):
193 III, 10. 2. 3 | intake to less than 1,5 g (3,8 g) per day, an increased
194 III, 10. 2. 3 | to less than 1,5 g (3,8 g) per day, an increased intake
195 III, 10. 2. 4 | Washington~ ~Gao J, Shan G, Sun B, Thompson PJ, Gao
196 III, 10. 2. 4 | Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998):
197 III, 10. 2. 4 | Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli
198 III, 10. 2. 4 | Kallioniemi OP, Sauter G (2001): Tissue microarrays
199 III, 10. 2. 5 | 377-82~Madigan S, Moran G, Schuengel C (2007): Unresolved
200 III, 10. 3. 1 | Oberaigner W, Pershagen G, Ruano-Ravina A, Ruosteenoja
201 III, 10. 3. 2 | concentrations (TEq) of ca. 10 pg/g in Hungary to ca. 40 pg/
202 III, 10. 3. 2 | in Hungary to ca. 40 pg/g in the Netherlands. The
203 III, 10. 3. 2 | concentrations are about 10 pg/g (range of 5-20) in most
204 III, 10. 3. 2 | of for S-PBDE of 2.49 ng/g fat which is comparable
205 III, 10. 3. 2 | MA Palacios, MM Gomez, G Morrison, S Rauch, C McLeod,
206 III, 10. 4. 2 | human health (100 bacteria/g). However, in RTE fishery
207 III, 10. 4. 2 | samples over the 100 cfu/g limit were made indicating
208 III, 10. 4. 2 | found in trouts: 0.02µg/g fish based on a TDI (Tolerable
209 III, 10. 4. 2 | WHO recommendation of 400 g fruit and vegetables/day (
210 III, 10. 4. 2 | in case of an emergency; (g) that the feed and food
211 III, 10. 5. 1 | Planning. Sweden.~Richardson G, Eick S, Jones R (2005):
212 III, 10. 5. 1 | Simoni M, Viegi G, Canciani M, Sestini P (
213 III, 10. 5. 1 | Gunnarsson K, Runeson R, Smedje G (2007) Physiological and
214 III, 10. 5. 2 | 256.~ ~Jones A, Bentham G. (1997): Health service
215 III, 10. 5. 2 | January 23, 2008)~ ~O'Reilly G, O'Reilly D, Rosato M, Connolly
216 III, 10. 6. 1 | R, Van Kesteren J, Hideg G, Nevala S (2005): The burden
217 III, 10. 6. 2 | University Press.~ ~Dahlgren, G. & Whitehead, M. (1991).
218 III, 10. 6. 2 | Breeze E, Cambois E, Costa G, Geurts JJM, Lahelma E,
219 IV, 11. 6. 5 | 18(2), p 364.~ ~Carrin G, Hanvoravongchai P (2003): "
220 IV, 11. 6. 5 | McDaid D, Thornicroft G (2005): Mental health II:
221 IV, 11. 6. 5 | Welfare and Sport.~ ~ ~Mooney G, HallJ et al. (1991): "Utilisation
222 IV, 11. 6. 5 | Economics 10: 475–480.~ ~Mooney G, Hall J et al. (1992): "
223 IV, 12. 5 | Disease registers (e. g. cancer, myocardial infarction,
224 IV, 12. 5 | Sentinel Networks (e. g. diseases not under mandatory
225 IV, 12. 5 | Surveillance Measures(e. g. Notifiable Infectious diseases)~-
226 IV, 12. 5 | Administrative data (e. g. health insurance data,
227 IV, 12. 5 | staff)~- Process data (e. g. data on health care supply
228 IV, 12. 5 | Data from Surveys (e. g. population representative
229 IV, 12. 10 | vegetables, preferably 600 g/d for adults and children (>
230 IV, 12. 10 | 10 years of age) and 400 g/d for children (4-10 years
231 IV, 12. 10 | some cases federal) laws e. g. against smoking at public
232 IV, 12. 10 | children/adolescents (see e. g. www o) including quit-lines (
233 IV, 12. 10 | non-governmental organisations (e. g. German Medical Association/
234 IV, 12. 10 | since 2004): targets e. g. prevention of diabetes
235 IV, 12. 10 | local infrastructure (e. g. cycle paths, public gyms
236 IV, 12. 10 | self-help organizations (e. g. drug counselling centres).~ ~
237 IV, 12. 10 | different sorts of drugs (e. g. “Quit the shit”-program
238 IV, 12. 10 | on health behaviour (e. g. information concerning
239 IV, 12. 10 | radiation there are, e. g., X-ray diagnostics in medicine,
240 IV, 12. 10 | early warning systems (e. g. on heat waves) that are
241 IV, 12. 10 | additional information see e. g. German Registry for Somatic
242 IV, 12. 10 | bioethical subjects see e. g. Federal Ministry of Justice (
243 IV, 12. 10 | population who eat at least 500 g fruit and/or vegetables
|
|
| |
